Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
688235.SS - BeOne Medicines AG
BeOne Medicines AG at TD Cowen Healthcare Conference
Mar 02, 2026 / 02:10PM GMT
=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
All right, well, welcome everybody to the forty-sixth annual healthcare conference from TD Cowen here in Boston. I'm Yaron Weber, biotech analyst, along with my colleague Jayna Hun. It's a great pleasure to kick off the conference on our end with a fireside chat with B1 Medicines.
With us today to my left is Aaron Rosenberg, Chief Financial Officer, and then to his left Mark Lanassa, Chief Medical Officer of Solid Tumor Tumors. Gentlemen, thanks for joining us. We appreciate it.
Thank you.
So lots to talk. About, Erin, maybe let me start with you because this is we're sort of fresh off the guidance.
The guidance was 6.2 to 6.4 million on revs on the heels of another nice rookinza beat
Trustpilot
